Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500μg vs Fluticasone Propionate 500μg in Patients with Corticosteroid-Dependent Asthma V: Results

被引：0
|
作者：
Willem R. Pieters
Bo Lundbäck
Seema Sondhi
Martin J. Price
Robert M.A. Thwaites
机构：
[1] Elkerliek Ziekenhuis,Respiratory Unit
[2] National Institute for Working Life,Global Health Outcomes
[3] Glaxo Wellcome,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Asthma; Adis International Limited; Fluticasone Propionate; Salmeterol; Formoterol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Methods: An economic analysis was performed to compare the cost effectiveness of a new formulation combining salmeterol 50μg and fluticasone propionate 500μg in a multidose dry powder (Diskus™) inhaler (n = 167) with that of fluticasone propionate (FP) 500μg (n = 165) also delivered via the Diskus™ in patients with corticosteroid-dependent asthma. Clinical data were obtained from a recent European multicentre trial; the economic analysis adopted a Swedish healthcare perspective.
引用
收藏
页码：29 / 34
页数：5
相关论文
共 50 条
  • [41] Salmeterol/fluticasone propionate (50/100 μg) in combination in a Diskus™ inhaler (Seretide™) is effective and safe in children with asthma
    Van den Berg, NJ
    Ossip, MS
    Hederos, CA
    Anttila, H
    Ribeiro, BL
    Davies, PI
    PEDIATRIC PULMONOLOGY, 2000, 30 (02) : 97 - 105
  • [42] The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children
    Barnes, NC
    Thwaites, RMA
    Price, MJ
    RESPIRATORY MEDICINE, 1999, 93 (06) : 402 - 407
  • [43] Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily
    Busse, W
    Koenig, SM
    Oppenheimer, J
    Sahn, SA
    Yancey, SW
    Reilly, D
    Edwards, LD
    Dorinsky, PM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (01) : 57 - 65
  • [44] The salmeterol/fluticasone propionate (50/250mcg) dry powder combination Diskus® has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma.
    Lumry, W
    Windom, H
    Mendelson, L
    Pedinoff, A
    Prillaman, B
    Baitinger, L
    Woodring, A
    House, K
    Shah, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S132 - S132
  • [45] Fluticasone propionate HFA134a significantly improves asthma control in inhaled corticosteroid-dependent asthmatics
    Pearlman, D
    Shrewsbury, SB
    Herje, N
    Fischer, T
    Wu, W
    Kerwin, E
    ALLERGY, 2002, 57 : 340 - 340
  • [46] The efficacy and safety of fluticasone propionate (250 μg)/salmeterol (50 μg) combined in the diskus inhaler for the treatment of COPD
    Hanania, NA
    Darken, P
    Horstman, D
    Reisner, C
    Lee, B
    Davis, S
    Shah, T
    CHEST, 2003, 124 (03) : 834 - 843
  • [47] Fluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthma
    Katz, Y
    Lebas, FX
    Medley, H
    Robson, R
    CLINICAL THERAPEUTICS, 1998, 20 (03) : 424 - 437
  • [48] Oropharyngeal candidiasis with dry-powdered fluticasone propionate:: 500 μg/day versus 200 μg/day
    Kurt, E.
    Yidirim, H.
    Kiraz, N.
    Orman, A.
    Metintas, M.
    Akgun, Y.
    Erginel, S.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2008, 36 (01) : 17 - 20
  • [49] Clinical Equivalence of a Salmeterol/Fluticasone Propionate Combination Product (50/500μg) Delivered via a Chlorofluorocarbon-Free Metered-Dose Inhaler with the Diskus™ in Patients with Moderate to Severe Asthma
    J. A. van Noord
    H. Lill
    T. Carrillo Diaz
    A. P. Greefhorst
    P. Davies
    Clinical Drug Investigation, 2001, 21 : 243 - 255
  • [50] Comparative effectiveness of salmeterol/fluticasone propionate combination 50/500 BID delivered via metered dose inhaler or diskus in patients with reversible airways obstruction
    van Noord, JA
    Lill, H
    Carillo, T
    Davies, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S15 - S15
12345